Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huafu Li

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Cancer|April 1, 2020
A thioredoxin reductase inhibitor ethaselen induces growth inhibition and apoptosis in gastric cancerWang Wu, Zhiying Yang, Xing Xiao, et al.
Cell Reports|January 25, 2026
A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cellsLinxiang Lan, Huafu Li, Shiwei Zhang, et al.
Cancer Letters|May 30, 2026
Exosomal circFXR1 drives immune evasion and tumor progression through dual regulation of PD-L1 and mTOR signaling in gastric cancerHongwu Chu, Xin Liu, Xiaomei Zhuang, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2021
Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancerHaiyong Zhang, Jing Wu, Jinqiu Yuan, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 16, 2022
Retraction Note: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancerHaiyong Zhang, Jing Wu, Jinqiu Yuan, et al.
Sensors (Basel, Switzerland)|May 20, 2022
QUantitative and Automatic Atmospheric Correction (QUAAC): Application and ValidationShumin Liu, Yunli Zhang, Limin Zhao, et al.
Bioactive Materials|March 26, 2026
Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia-reperfusion lung injury and pneumoniaHaoxiang Yuan, Wei Wang, Jian Ma, et al.
International Journal of Surgery (London, England)|October 22, 2024
METTL16 inhibits pancreatic cancer proliferation and metastasis by promoting MROH8 RNA stability and inhibiting CAPN2 expression - experimental studiesTingzhuang Yi, Chunming Wang, Xia Ye, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2025
LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradationTingzhuang Yi, Juan He, Meini Pan, et al.
Frontiers in Cell and Developmental Biology|September 9, 2021
PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair PathwayHuafu Li, Chunming Wang, Linxiang Lan, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Cancer|April 1, 2020
A thioredoxin reductase inhibitor ethaselen induces growth inhibition and apoptosis in gastric cancerWang Wu, Zhiying Yang, Xing Xiao, et al.
Cell Reports|January 25, 2026
A Jagged1-regulated hybrid-EMT state identifies pancreatic cancer stem cellsLinxiang Lan, Huafu Li, Shiwei Zhang, et al.
Cancer Letters|May 30, 2026
Exosomal circFXR1 drives immune evasion and tumor progression through dual regulation of PD-L1 and mTOR signaling in gastric cancerHongwu Chu, Xin Liu, Xiaomei Zhuang, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 20, 2021
Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancerHaiyong Zhang, Jing Wu, Jinqiu Yuan, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 16, 2022
Retraction Note: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancerHaiyong Zhang, Jing Wu, Jinqiu Yuan, et al.
Sensors (Basel, Switzerland)|May 20, 2022
QUantitative and Automatic Atmospheric Correction (QUAAC): Application and ValidationShumin Liu, Yunli Zhang, Limin Zhao, et al.
Bioactive Materials|March 26, 2026
Inhalable PD-L1-engineered hybrid cellular vesicles suppress excessive neutrophil activation and restore mitochondrial homeostasis to alleviate ischemia-reperfusion lung injury and pneumoniaHaoxiang Yuan, Wei Wang, Jian Ma, et al.
International Journal of Surgery (London, England)|October 22, 2024
METTL16 inhibits pancreatic cancer proliferation and metastasis by promoting MROH8 RNA stability and inhibiting CAPN2 expression - experimental studiesTingzhuang Yi, Chunming Wang, Xia Ye, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 3, 2025
LL22NC03-N14H11.1 regulates the m6A modification of MYC and promotes glycolytic activity in hepatocellular carcinoma cells by inhibiting IGF2BP3 ubiquitination degradationTingzhuang Yi, Juan He, Meini Pan, et al.
Frontiers in Cell and Developmental Biology|September 9, 2021
PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair PathwayHuafu Li, Chunming Wang, Linxiang Lan, et al.
Pageof 3